Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse MKT  >  CEL-SCI Corporation    

 SummaryNewsCalendarCompanyFinancialsRevisions 
Financials ($)
More Financials
Company
CEL-SCI Corp. is a biotechnology company, which is involved in the research and development of investigational immunotherapy products for the treatment of cancer and infectious diseases.The company's lead investigational therapy, Multikine is currently in a pivotal phase 3 clinical trial against... 
More about the company
Latest news on CEL-SCI CORPORATION
06/09 CEL SCI : to Present at the Fifth Annual Marcum MicroCap Conference
06/07 CEL SCI : NEW STORY CEL-SCI to Present at LD Micro Invitational
06/07 CEL SCI : to Present at LD Micro Invitational
06/02 CEL SCI : Announces the Closing of Its $5 Million Registered Direct Offering
06/01 CEL SCI : NEW STORY CEL-SCI Reports Monthly Patient Enrollment in May for Its Ph..
06/01 CEL SCI : Reports Monthly Patient Enrollment in May for Its Phase 3 Head and Nec..
05/31 CEL SCI : NEW STORY CEL-SCI to Present At the Fifth Annual Marcum Microcap Confe..
05/31 CEL SCI : to Present at the Fifth Annual Marcum MicroCap Conference
05/24 CEL SCI : NEW STORY CEL-SCI Announces the Closing of Its $5 Million Registered D..
05/24 CEL SCI : Announces the Closing of Its $5 Million Registered Direct Offering
More news
Sector news : Bio Therapeutic Drugs
06/25 NOVARTIS : SC requests solicitor general to consider on biosimilars
06/24DJMedpace Files for IPO
06/24DJMEDIVATION : Glass Lewis Backs Medivation Board in Sanofi Dispute
06/24 MEDIVATION : Glass Lewis Recommends Medivation's Stockholders Support the Compan..
06/24 MEDIVATION : Glass Lewis Recommends Medivation’s Stockholders Support the ..
More sector news : Bio Therapeutic Drugs
Advertisement
Income Statement Evolution
More Financials